Effect of Botulinum Toxin on Disabling Neuropathic Pain: A Case Presentation Suggesting a New Therapeutic Strategy

PM and R

Volumn 9, Issue 2, 2017, Pages 200-203

  Buonocore, Michelangelo ^a   Demartini, Laura ^a   Mandrini, Silvia ^b   Dall'Angelo, Anna ^b   Dalla Toffola, Elena ^b  

^a IRCCS   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; CAPSAICIN; CLONAZEPAM; CLONIDINE; GABAPENTIN; GUANETHIDINE; LIDOCAINE; METHYLPREDNISOLONE; OXCARBAZEPINE; ACETYLCHOLINE RELEASE INHIBITOR;

ABNORMAL POSTURE; ADD ON THERAPY; ADULT; ALLODYNIA; ANKLE FOOT ORTHOSIS; ARTICLE; AXONAL NEUROPATHY; CASE REPORT; COMPLEX REGIONAL PAIN SYNDROME TYPE II; CRUTCH; CYANOSIS; DISABILITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSESTHESIA; ELECTROMYOGRAPHY; ELECTRONEUROGRAPHY; ELECTROSTIMULATION; FEMALE; FOOT EDEMA; HEMATOMA; HOSPITAL DISCHARGE; HUMAN; HYPESTHESIA; LEG MUSCLE; MIDDLE AGED; MUSCLE TONE; NERVE TRANSECTION; NEUROMA; NEUROPATHIC PAIN; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOTHERAPY; POSTERIOR TIBIAL NERVE; PRIORITY JOURNAL; SPINAL CORD STIMULATION; SURAL NERVE; SYMPATHETIC BLOCKING; TALUS; TIBIAL NERVE; TREATMENT RESPONSE; TROCHLEAR NERVE DISEASE; WALKING; ANALGESIA; ANKLE; IATROGENIC DISEASE; INNERVATION; NEURALGIA; PAIN MEASUREMENT; PROCEDURES;

ACETYLCHOLINE RELEASE INHIBITORS; ANKLE JOINT; BOTULINUM TOXINS, TYPE A; FEMALE; HUMANS; IATROGENIC DISEASE; MIDDLE AGED; NEURALGIA; PAIN MANAGEMENT; PAIN MEASUREMENT;

EID: 85007436445     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2016.10.014     Document Type: Article

References (18)

1. 1 Harden, R.N., Cole, P.A., New developments in rehabilitation of neuropathic pain syndromes. Neurol Clin 16 (1998), 937–950.
2. 2 Buonocore, M., Rehabilitation in chronic neuropathic pain syndromes. Direct Rehabil Counsel 13 (2002), 117–125.
3. 3 Akyuz, G., Kenis, O., Physical therapy modalities and rehabilitation techniques in the treatment of neuropathic pain. Am J Phys Med Rehabil 93 (2014), 253–259.
4. 4 Baron, R., Binder, A., Wasner, G., Neuropathic pain: Diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 9 (2010), 807–819.
5. 5 Nickel, F.T., Seifert, F., Lanz, S., Maihofner, C., Mechanisms of neuropathic pain. Eur Neuropsychopharmacol 22 (2012), 81–91.
6. 6 Parsons, B., Schaefer, C., Mann, R., et al. Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United States. J Pain Res 6 (2013), 459–469.
7. 7 Hurley, R.W., Adams, M.C., Benzon, H.T., Neuropathic pain: Treatment guidelines and updates. Curr Opin Anaesthesiol 26 (2013), 580–587.
8. 8 Argoff, C.E., A focused review on the use of botulinum toxins for neuropathic pain. Clin J Pain 18 (2002), S177–S181.
9. 9 Rawicki, B., Sheean, G., Fung, V.S.C., Goldsmith, S., Morgan, C., Novak, I., Botulinum toxin assessment, intervention and aftercare for paediatric and adult niche indications including pain: International consensus statement. Eur J Neurol 17 (2010), S122–S134.
10. 10 Ranoux, D., Attal, N., Morain, F., Bouhassira, D., Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol 64 (2008), 274–283.
11. 11 Bach-Rojecky, L., Lackovi, Z., Central origin of the antinociceptive action of botulinum toxin type A. Pharmacology, biochemistry and behavior 94 (2009), 234–238.
12. 12 Favre-Guilmard, C., Auguet, M., Chabrier, P.E., Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models. Eur J Pharmacol 617 (2009), 48–53.
13. 13 Costigan, M., Woolf, C.J., Pain molecular mechanisms. J Pain 1 (2000), S35–S44.
14. 14 Van Hilten, J.J., Movement disorders in complex regional pain syndrome. Pain Med 11 (2010), 1274–1277.
15. 15 Birklein, F., Schlereth, T., Complex regional pain syndrome─significant progress in understanding. Pain 156 (2015), S94–S103.
16. 16 Wall, P.D., Gutnick, M., Properties of afferent nerve impulses originating from a neuroma. Nature 248 (1974), 740–743.
17. 17 Nikolajsen, L., Black, J.A., Kroner, K., Jensen, T.S., Waxman, S.G., Neuroma removal for neuropathic pain: Efficacy and predictive value of lidocaine infusion. Clin J Pain 26 (2010), 788–793.
18. 18 Ochoa, J., Torebjörk, H.E., Culp, W.J., Schady, W., Abnormal spontaneous activity in single sensory nerve fibers in humans. Muscle Nerve 5 (1982), S74–S77.